A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose

Autor: Stephan Kress, Peter Bramlage, Ariel Zisman, Thorsten Siegmund, Anja Borck

Publikováno v: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Stephan Kress,1 Anja Borck,2 Ariel Zisman,3 Peter Bramlage,4,5 Thorsten Siegmund6 1Diabeteszentrum, Vinzentius-Krankenhaus, Landau, Germany; 2Medical Department, Sanofi, Berlin, Germany; 3The Endocrine Center of Aventura, Aventura, FL, USA; 4Institut

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0af84b3bb332a420981b927fcb3a7eb8
http://europepmc.org/articles/PMC7987255

Comparison of Human Premixed and Basal Plus Short-Acting Insulin Regimens for Individuals With Type 2 Diabetes During Ramadan Fasting

Autor: Ammar Mohammed Saeed Abdullah Almomin, Mahmood Thamer Altemimi, Abbas Ali Mansour, Husam Jihad Imran, Ali Hussain Ali Alhamza, Samih A Odhaib

Publikováno v: Cureus

Background Premixed insulin and basal insulin plus short-acting insulin regimens may be of value for treating individuals with type 2 diabetes (T2DM) who are fasting during Ramadan due to simplicity and better compliance. The objective of this study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2be201bb57eb5ea36a1d2970993ced1
https://doi.org/10.7759/cureus.11976

Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials

Autor: Mark R Lankisch, Marie Paule Dain, Stefano Del Prato, David R. Owens, Peter R. Mullins

Publikováno v: Primary Care Diabetes. 10(1):51-59

AimsTo evaluate the efficacy and safety of adding a single bolus dose of insulin glulisine to basal insulin (‘basal-plus’) in persons with type 2 diabetes.MethodsData from patients with poor glycemic control on oral antihyperglycemic drugs who we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3386631eb501ab2d7f270556941fc614

Safety and efficacy of a basal-plus regimen with insulin glargine and insulin glulisine for elderly patients with high cardiovascular risk and type 2 diabetes mellitus

Autor: R, Gómez-Huelgas, J, Sabán-Ruiz, F J, García-Román, N, Quintela-Fernández, J M, Seguí-Ripoll, M V, Bonilla-Hernández, G, Romero-Meliá

Publikováno v: REVISTA CLINICA ESPANOLA
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

Objectives: To assess the safety and efficacy of a basal-plus (BP) regimen with insulin glargine (as basal insulin) and insulin glulisine (as prandial insulin) with the main meal for elderly patients with type 2 diabetes mellitus (DM2) and high cardi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8eab04f2bc27746bd61fdf38dd0d5b4b
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2273

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.